In an exclusive interview with Regulatory Rapporteur, Celia Lourenco, Director General, Biologic and Radiopharmaceutical Drugs Directorate, and Dr. J. Patrick Stewart, Director General, Therapeutic Products Directorate, both at Health Canada, talk about how the agency ensures the safety of pharmaceutical and health products.
Authors:
Aman Khera, MBA, FTOPRA, FRAPS
VP, Regulatory Science, Strategy and Innovation
